- Home
- ENVB vs AUUD Comparison
ENVB vs AUUD Comparison
Compare ENVB & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- AUUD
- Stock Information
- Founded
- ENVB 1994
- AUUD 2012
- Country
- ENVB United States
- AUUD United States
- Employees
- ENVB N/A
- AUUD N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- AUUD Computer Software: Prepackaged Software
- Sector
- ENVB Health Care
- AUUD Technology
- Exchange
- ENVB Nasdaq
- AUUD Nasdaq
- Market Cap
- ENVB 3.2M
- AUUD 2.9M
- IPO Year
- ENVB N/A
- AUUD 2021
- Fundamental
- Price
- ENVB $1.21
- AUUD $4.03
- Analyst Decision
- ENVB Strong Buy
- AUUD
- Analyst Count
- ENVB 1
- AUUD 0
- Target Price
- ENVB $10.00
- AUUD N/A
- AVG Volume (30 Days)
- ENVB 419.0K
- AUUD 52.3K
- Earning Date
- ENVB 05-14-2025
- AUUD 06-10-2025
- Dividend Yield
- ENVB N/A
- AUUD N/A
- EPS Growth
- ENVB N/A
- AUUD N/A
- EPS
- ENVB N/A
- AUUD N/A
- Revenue
- ENVB N/A
- AUUD N/A
- Revenue This Year
- ENVB N/A
- AUUD N/A
- Revenue Next Year
- ENVB N/A
- AUUD N/A
- P/E Ratio
- ENVB N/A
- AUUD N/A
- Revenue Growth
- ENVB N/A
- AUUD N/A
- 52 Week Low
- ENVB $1.01
- AUUD $2.88
- 52 Week High
- ENVB $11.97
- AUUD $31.62
- Technical
- Relative Strength Index (RSI)
- ENVB 38.00
- AUUD 48.78
- Support Level
- ENVB $1.11
- AUUD $3.90
- Resistance Level
- ENVB $1.31
- AUUD $4.89
- Average True Range (ATR)
- ENVB 0.11
- AUUD 0.35
- MACD
- ENVB 0.04
- AUUD 0.01
- Stochastic Oscillator
- ENVB 26.33
- AUUD 27.46
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.